Bedeutung von Urokinase-Plasminogen-Aktivator für das Wachstum und die Stabilität arteriosklerotischer Gefäßläsionen im Apolipoprotein-E-Knockout-Mausmodell

Bedeutung von Urokinase-Plasminogen-Aktivator für das Wachstum und die Stabilität arteriosklerotischer Gefäßläsionen im Apolipoprotein-E-Knockout-Mausmodell

Bibliographic Details
Main Author:	Schremmer, Carmen
Other Authors:	Schäfer, Katrin Prof. Dr.
Format:	Doctoral Thesis
Language:	deu
Published:	2013
Subjects:	610 Atherosclerosis Restenosis Arterial thrombosis mouse model Urokinase Urokinase receptor Medizin (PPN619874732)
Online Access:	http://hdl.handle.net/11858/00-1735-0000-0001-BBBE-C http://nbn-resolving.de/urn:nbn:de:gbv:7-11858/00-1735-0000-0001-BBBE-C-9

Similar Items

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
by: Shirin Kouhpayeh, et al.
Published: (2017-01-01)

Urokinase-type plasminogen activator is a modulator of synaptic plasticity in the central nervous system: implications for neurorepair in the ischemic brain
by: Manuel Yepes
Published: (2020-01-01)

Monitoring of chemotherapy successfulness of Platina/Taxol chemotherapy protocol by using determination of serum urokinase plasminogen activator (uPA) and soluble urokinase plasminogen activator receptor (suPAR) in patients with ovarian carcinoma FIGO II
by: Dženita Ljuca, et al.
Published: (2007-05-01)

Specific inhibitors of urokinase plasminogen activator for treatment of cancers; In silico approach
by: Benjamin Talbot, et al.
Published: (2020-05-01)

Serum levels of urokinase-type plasminogen activator in healthy dogs and oncologic canine patients
by: Sofia C. Ramos, et al.
Published: (2017-08-01)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
by: Chung-Ze Wu, et al.
Published: (2021-03-01)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
by: Torry A. Tucker, et al.
Published: (2021-02-01)

Urokinase plasminogen activator expression in canine malignant mammary tumours by immunohistochemical study
by: Golshahi Hannaneh, et al.
Published: (2013-12-01)

Concentrations of plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in induced sputum of asthma patients after allergen challenge
by: Krzysztof Kowal,, et al.
Published: (2010-04-01)

Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator
by: Yung-Chuan Ho, et al.
Published: (2014-06-01)

Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
by: Ioannis Griveas, et al.
Published: (2021-07-01)

Microparticules : activité fibrinolytique dans le choc septique et approche innovante de standardisation
by: Cointe, Sylvie
Published: (2015)

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation
by: Noboru Ichihara, et al.
Published: (2017-10-01)

Urokinase gene 3'-UTR T/C polymorphism is not associated with bladder cancer
by: Wu Hsi-Chin, et al.
Published: (2004-01-01)

Urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type-1 (PAI-1) in breast cancer - correlation with traditional prognostic factors
by: Lampelj Maja, et al.
Published: (2015-12-01)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications
by: Anna Li Santi, et al.
Published: (2021-04-01)

Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase
by: Dominika Wójtowicz, et al.
Published: (2018-10-01)

Comparison of Video-Assisted Thoracoscopic Surgery and Intrapleural Urokinase as an Initial Treatment for Parapneumonic Effusion and Thoracic Empyema
by: Shungo Yukumi, et al.
Published: (2014-05-01)

Comparison of Video-Assisted Thoracoscopic Surgery and Intrapleural Urokinase as an Initial Treatment for Parapneumonic Effusion and Thoracic Empyema
by: Shungo Yukumi, et al.
Published: (2014-05-01)

Role of multidomain structure of urokinase in regulation of growth and remodeling of vessels
by: V. A. Tkachuk, et al.
Published: (2013-12-01)

Targeting uPAR in diabetic vascular pathologies*
by: Martyna Durak-Kozica, et al.
Published: (2019-12-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Urokinase vs Tissue-Type Plasminogen Activator for Thrombolytic Evacuation of Spontaneous Intracerebral Hemorrhage in Basal Ganglia
by: Yuqian Li, et al.
Published: (2017-08-01)

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder
by: Line H. Dohn, et al.
Published: (2021-05-01)

TLR4 Response to LPS Is Reinforced by Urokinase Receptor
by: Yulia Kiyan, et al.
Published: (2020-12-01)

Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
by: Gary Tincknell, et al.
Published: (2021-08-01)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
by: Burcin Özdirik, et al.
Published: (2020-05-01)

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis
by: Ery Olivianto, et al.
Published: (2019-01-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Inhibition of Urokinase-Type Plasminogen Activator Expression by Macelignan in Porphyromonas gingivalis Supernatant-Induced Human Oral Epithelial Cells
by: YANTI
Published: (2010-03-01)

Effect of remission induction therapy on the level of soluble urokinase plasminogen activator receptor in acute myeloid leukemia
by: Eman Qassim Ahmed, et al.
Published: (2020-01-01)

Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation
by: Angela S. Koh, et al.
Published: (2017-11-01)

Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis
by: Chang DH, et al.
Published: (2017-01-01)

Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China
by: Rongrong Zhang, et al.
Published: (2021-07-01)

Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus
by: Chung-Ze Wu, et al.
Published: (2019-11-01)

MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
by: Meng D, et al.
Published: (2018-11-01)

Serum levels of soluble urokinase plasminogen activator receptor as a new inflammatory marker in adolescent obesity
by: Ummugulsum Can, et al.
Published: (2017-01-01)

Studying the Activity of Fibroblast Growth Factor 18 and Urokinase Plasminogen Activator Receptor Promoters in Two Colon Cancer Cell Lines
by: Ladan Teimoori-Toolabi, et al.
Published: (2009-01-01)

Urokinase receptor regulates nerve regeneration through its interaction with α5β1-integrin
by: P.S. Klimovich, et al.
Published: (2020-05-01)

Intrapleural urokinase directly under medical thoracoscopy for the diagnosis of tuberculous pleurisy
by: Satoshi Terashita, et al.
Published: (2020-01-01)